Psychedelic Science Summit
November 1-3, 2019 — Austin, Texas
Join MAPS and the psychedelic community at Fair Market in Austin for the first Psychedelic Science Summit!
This conference will feature lectures and panels from leaders of the psychedelic renaissance. You’ll have a chance to connect with the fast-growing international psychedelic community and explore the opportunities and challenges that lay ahead for the expanding fields of psychedelic science, medicine, and spirituality.
For this journey, please bring an open mind and a jacket or sweater. Believe it or not, Austin does get cold this time of year. Right now we are expecting highs of 62-66 and lows of 42-45!
Continuing Education (CE) credits are available for mental health practitioners. At least 12 CE hours will be available. Please see here for details.
Conference Tickets are sold out! Click here to join the waiting list.
Tickets for the Benefit Dinner on Friday and the Celebration on Saturday (Powered by Light Pump) are still available.
Together, we’ll discover the latest research into psychedelic therapy for the treatment of posttraumatic stress disorder (PTSD), addiction, depression, anxiety, and more. We’ll also learn from the experts about the risks and benefits of psychedelics such as MDMA, LSD, psilocybin, ketamine, and ayahuasca for mental health and personal growth, and the powerful role this work is playing in policy, law, and culture. This event is a 600 person single-track, single-stage summit, featuring presentations from MAPS Founder Rick Doblin, Ph.D., mycologist Paul Stamets, addiction expert Dr. Carl Hart, and a live interview with Tim Ferriss and Marcela Ot’alora. Full schedule to be announced soon.
The Psychedelic Science Summit is part of the Psychedelic Science series of conferences, which have been bringing the international psychedelic community together since 2010.
Carl Hart, Ph.D. Professor, Columbia UniversityRead Bio
Carl Hart, Ph.D.
Carl Hart is the Chair of the Department of Psychology at Columbia University. He is also the Ziff Professor of Psychology in the Departments of Psychology and Psychiatry. Professor Hart has published numerous scientific and popular articles in the area of neuropsychopharmacology and is co-author of the textbook Drugs, Society and Human Behavior (with Charles Ksir). His most recent book, “High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society,” was the 2014 winner of the PEN/E.O. Wilson Literary Science Writing Award. Professor Hart has appeared on multiple podcasts, radio and television shows including Real Time with Bill Maher and The O’Reilly Factor. He has also appeared in several documentary films including the award-winning “The House I Live In.” His essays have been published in several popular publications including The New York Times, Scientific American, The Nation, Ebony, The Root, and O Globo (Brazil’s leading newspaper).
Tim Ferriss Entrepreneur, Author, and PodcasterRead Bio
Tim Ferriss has been called “a cross between Jack Welch and a Buddhist monk” by The New York Times. He is one of Fast Company’s “Most Innovative Business People” and an early-stage tech investor/advisor in Uber, Facebook, Twitter, Shopify, Duolingo, Alibaba, and 50+ other companies. He is also the author of five #1 New York Times and Wall Street Journal bestsellers, including The 4-Hour Workweek. The Observer and other media have named him “the Oprah of audio” due to the influence of his podcast, The Tim Ferriss Show, which has exceeded 400 million downloads. His latest book is Tribe of Mentors: Short Life Advice from the Best in the World.
Paul Stamets Speaker, Author, Mycologist, Medical Researcher, and EntrepreneurRead Bio
Paul Stamets, speaker, author, mycologist, medical researcher, and entrepreneur, is considered an intellectual and industry leader in fungi: habitat, medicinal use, and production. He lectures extensively to deepen the understanding and respect for the organisms that literally exist under every footstep taken on this path of life. His presentations cover a range of mushroom species and research showing how mushrooms can help the health of people and planet. His central premise is that habitats have immune systems, just like people, and mushrooms are cellular bridges between the two. Our close evolutionary relationship to fungi can be the basis for novel pairings in the microbiome that lead to greater sustainability and immune enhancement.
Paul’s philosophy is that “MycoDiversity is BioSecurity.” He sees the ancient Old Growth forests of the Pacific Northwest as a resource of incalculable value, especially in terms of its fungal genome. A dedicated hiker and explorer, his passion is to preserve and protect as many ancestral strains of mushrooms as possible from these pristine woodlands. His research is considered breakthrough by thought leaders for creating a paradigm shift for helping ecosystems worldwide.
Paul is the author of six books (including Mycelium Running: How Mushrooms Can Help Save The World, Growing Gourmet and Medicinal Mushrooms, and Psilocybin Mushrooms of the World), he has discovered and named numerous new species of psilocybin mushrooms, and is the founder and owner of Fungi Perfecti, LLC, makers of the Host Defense Mushrooms supplement line.
Betty Aldworth Executive Director of Students for Sensible Drug Policy (SSDP)Read Bio
Betty Aldworth is the Executive Director of Students for Sensible Drug Policy where she supports students and young people united to build a more sensible future through drug policies rooted in safety, justice, and education. Since joining the team in 2014, she has led the organization through its most substantial growth period: SSDP’s member base and campuses have doubled, global presence has quadrupled, and as a result the policy change and education efforts members are leading have grown immeasurably.
From 2009 until 2014, Betty specialized in community outreach, public relations, advocacy, and policy reform as a consultant to or staffer for cannabis-related businesses and nonprofit organizations. She served as spokesperson and advocacy director for Colorado’s successful 2012 Campaign to Regulate Marijuana Like Alcohol, the collaborative committee responsible for legalizing, taxing and regulating marijuana for adults in Colorado and was the Deputy Director of the National Cannabis Industry Association in 2013, the organization’s fastest year of growth. Prior to her work in marijuana policy and medical cannabis, she was a volunteer leadership professional with some of Denver’s most well-respected nonprofit organizations, ultimately leading a team of 4,000 volunteers who contributed over 40,000 hours of service annually.
Betty’s early activism focused on anti-war, anti-apartheid, and environmental issues. Her fondest childhood memories include attending an annual Easter peace rally at the local nuclear testing facility, and she organized her first action at 13, a cleanup day at the local lake attended only by Betty and her mom. That action informed her commitment to “failing forward,” an approach which demands taking smart, managed risks and learning everything you can from them whether or not the result is a “success”. As an adult her activism centered around anti-war efforts; civic engagement; intersectional womens’ issues; and racial, economic, and social justice. Today, her primary issues of concern are ending mass incarceration, engaging citizens in the political process, and building economic justice; she understands that ending the War on Drugs is necessary but insufficient to replace the racist cycle of poverty and criminalization which continue to drive inequality and human rights abuses.
Betty lived and audited coursework at Deep Springs College, a small but elite academic and ranching community isolated in central eastern California. She has completed coursework in philosophy and women’s studies at Metropolitan State University of Denver, and periodically flirts with the idea of returning to complete her degree but then, as has always been the case, becomes absorbed with compelling work.
Ian Benouis, J.D. General Counsel, Veterans for Natural Rights (VNR)Read Bio
Ian Benouis, J.D.
Ian Benouis, J.D., is a West Point graduate, former Blackhawk helicopter pilot, and former U.S. Army officer and combat veteran who participated in Operation Just Cause in the Republic of Panama, the biggest operation in history directed towards the War on Drugs.
Ian has been healing himself for over 25 years with natural earth medicines and a spiritual practice. He is a student and practitioner of ethnobotany.
Ian has organized and participated in numerous trips with veterans to Mexico, Peru, and other locations for ethnobotanical healing.
This work has been captured in documentaries including: the just released "From Shock to Awe" and "Soldiers of the Vine." Veterans for Natural Rights (VNR) is a 501(c)(3) nonprofit dedicated to veteran healing and reintegration.
Amber Capone Co-Founder & Executive Director of VETS: Veterans Exploring Treatment Solutions, Inc.Read Bio
Amber has a history of fixing, building, and tenaciously seeking solutions to complex challenges. She is now embarking on her most critical work yet, serving as Co-Founder and Executive Director of VETS. As her own personal and professional life began to unravel upon Marcus’s separation from the military, she became determined not to become a victim, but to pursue victory for her own family, as well as countless others who are suffering. Amber possesses a heart for serving others, and a steadfast determination to make a difference.
Marcus Capone Co-Founder & Chairman of VETS: Veterans Exploring Treatment Solutions, Inc.Read Bio
Marcus is an entrepreneur and former Navy SEAL who spent a sizable portion of his 13-year military career deployed to a war zone. After Marcus’s transformational experience with Entheogenic medicines, he felt compelled to immediately begin helping friends who were also experiencing the same post-war challenges. Marcus has been involved with several start-up companies since leaving the military, and is the Co-Founder and Chairman of his charity, VETS: Veterans Exploring Treatment Solutions, Inc. VETS provides resources, research, and advocacy to improve the quality of life for U.S. combat veterans and their families. He is currently finishing his MBA at USC Marshall School of Business.
Rick Doblin, Ph.D. Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS)Read Bio
Rick Doblin, Ph.D.
Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife, two dogs, and empty rooms from three children, one of whom is in college and two have graduated.
Allison Feduccia, Ph.D. Senior Clinical Data Scientist, MAPS Public Benefit Corporation (MAPS PBC)Read Bio
Allison Feduccia, Ph.D.
Dr. Alli Feduccia is a Senior Clinical Data Scientist at MAPS Public Benefit Corporation. In this role, she analyzes data from clinical trials for publications and regulatory documents, and communicates findings with scientific and lay audiences. She is also Co-Founder and Director of Psychedelic.Support, an online platform to connect with mental health professionals. She earned a Ph.D. in Neuropharmacology from the University of Texas at Austin studying the effects of MDMA on behavior and neurochemical release in rodent models. She was a postdoctoral researcher at the University of California, San Francisco and at the National Institutes of Health where she investigated treatments for substance use disorders. Alli highly regards the opportunity to help generate scientifically based evidence on the therapeutic potential of psychedelics.
Jax Finkel Executive Director of Texas NORMLRead Bio
Jax Finkel is Executive Director for Texas NORML, the Austin Chapter of the National Organization for the Reform of Marijuana Laws (NORML), having also served as Volunteer Coordinator, Political / Legislative Director and Deputy Director. She has been involved in cannabis law reform since 2005 and has been an official Board Member since 2006. In her tenor, Jax has given hundreds of interviews and participated in many panel discussions and speaking engagements. She innovated the first ever cannabis-centric Voter's Guide in 2012 and continues to prepare the Texas NORML Voter's Guide for each election season. She helped spearhead the first Texas Chapter Training. She believes in freely sharing information and facilitating organizational growth. She created the curriculum and help organize and execute several dozen regional advocacy trainings between 2015 and present. She works closely with Texans for Responsible Marijuana Policy and the coalition partners along with many other cannabis groups. Jax is often at the Capitol pushing for cannabis law reform and building relationships with our Legislators. Cannabis law reform is her passion.
Sara Gael, M.A. Zendo Project DirectorRead Bio
Sara Gael, M.A.
Sara received her master’s degree in transpersonal counseling psychology at Naropa University. She began working with MAPS in 2012, coordinating psychedelic harm reduction services at festivals and events worldwide with the Zendo Project. Sara was an intern therapist for the MAPS Phase 2 clinical trial of MDMA-assisted psychotherapy for PTSD in Boulder, CO. She maintains a private practice as a psychotherapist specializing in trauma and non-ordinary states of consciousness. Sara believes that developing a comprehensive understanding of psychedelic medicines through research and education is essential for the health and well-being of individuals, communities, and the planet.
Natalie Ginsberg, M.S.W. MAPS Policy and Advocacy DirectorRead Bio
Natalie Ginsberg, M.S.W.
Natalie Lyla Ginsberg received her B.A. in history from Yale, and her master’s of social work (MSW) from Columbia. Before joining MAPS in 2014, Natalie worked as a Policy Fellow at the Drug Policy Alliance, where she helped legalize medical cannabis in her home state of New York, and worked to end New York’s race-based marijuana arrests. Natalie has also worked as a therapist at an alternative-sentencing court for prostitution and drug-related offenses, and as a middle school guidance counselor. At MAPS, Natalie works to disentangle science from political partisanship on Capitol Hill, at the United Nations, and beyond. She is also co-developing a psychedelic peace-building study with Imperial College, working with Palestinians and Israelis. Natalie is particularly inspired by the potential of psychedelics for healing systemic, intergenerational trauma, for building empathy and community, and for inspiring creative and innovative solutions.
George Greer, M.D. President, Heffter Research InstituteRead Bio
George Greer, M.D.
Dr. George Greer conducted over 100 therapeutic sessions with MDMA for 80 individuals from 1980 to 1985 with his psychiatric nurse wife, Requa Tolbert. He is a Distinguished Life Fellow of the American Psychiatric Association and Past President of the Psychiatric Medical Association of New Mexico. He was the Medical Director of the Heffter Research Institute from 1998 to 2017, when he became President. He is an investigator administering MDMA to therapists for the MAPS MDMA therapist training project in Santa Fe, NM.
Mellody Hayes, M.D. Physician at University of California, San FranciscoRead Bio
Mellody Hayes, M.D.
Mellody Hayes is a physician-writer and public speaker who trained in Sociology at Harvard College before training as a physician and anesthesiologist at UCSF. Known for her heart-centered, powerful public speaking, her writing, speaking, coaching, and work in palliative care serves to encourage us to develop a better relationship to human suffering, be it anxiety, depression, pain, or end of life crisis. She believes that each person has a story of possibility, even in the presence of great pain, to be discovered that is part of their personal medicine.
Sophia Korb, Ph.D. Researcher, Fadiman GroupRead Bio
Sophia Korb, Ph.D.
Sophia Korb received her Ph.D. from the Institute of Transpersonal Psychology in Palo Alto, CA. She has clinical experience with children and families with trauma, individuals with chronic psychiatric disabilities, people living with HIV/AIDS, veterans, people using substances, and people who are formerly incarcerated.
Her research interests include the experiences of people who use substances, harm reduction, trauma-informed therapies, applying machine learning to social science contexts, and evidence based policy and therapies. She is dedicated to puzzles of turning data from the world into useful information.
New realms of ethical, open science excite and motivate her work. She is passionate about collaboration with members of affected groups in anti-oppressive research.
Sophia lives in Washington, DC, with her younger sister, younger brother and dog.
Bia Labate, Ph.D. Executive Director of the Chacruna Institute for Psychedelic Plant MedicinesRead Bio
Bia Labate, Ph.D.
Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian anthropologist who immigrated to the U.S. in 2017. She has a Ph.D. in social anthropology from the State University of Campinas (UNICAMP), Brazil. Her main areas of interest are the study of plant medicines, drug policy, shamanism, ritual, and religion. She is Executive Director of the Chacruna Institute for Psychedelic Plant Medicines, an organization that provides public education about psychedelic plant medicines and promotes a bridge between the ceremonial use of sacred plants and psychedelic science. She is Adjunct Faculty at the East-West Psychology Program at the California Institute of Integral Studies (CIIS) in San Francisco, and Visiting Professor at the Center for Research and Post Graduate Studies in Social Anthropology (CIESAS) in Guadalajara. She is also Public Education and Culture Specialist at the Multidisciplinary Association for Psychedelic Studies (MAPS). She is co-founder of the Interdisciplinary Group for Psychoactive Studies (NEIP) in Brazil, and editor of NEIP’s website, as well as editor of the Mexican blog Drugs, Politics, and Culture. She is author, co-author, and co-editor of twenty-one books, one special-edition journal, and several peer-reviewed articles.
SGT(R) Jonathan Lubecky MAPS Veterans & Governmental Affairs LiaisonRead Bio
SGT(R) Jonathan Lubecky
Sgt. Lubecky graduated from the Citadel in 2015 with a degree in Political Science. He served in both the Marine Corps and the Army from 1995 to 2009, with a four-year hiatus from 1999 to 2003. Throughout his service in both branches, he was deployed in active combat zones. This interview gives unique insight into both Sgt. Lubecky’s service and the posttraumatic stress disorder he lives with. Sgt. Lubecky’s battles with PTSD inspired him to become involved with Veterans Affairs and in politics as an active lobbyist for Veterans.
Marcela Ot’alora, L.P.C. Principal Investigator for Phase 3 and Healthy Volunteer MDMA Studies in Boulder, ColoradoRead Bio
Marcela Ot’alora, L.P.C.
Marcela Ot’alora G. was born and raised in Colombia, S.A. and now lives in Boulder, Colorado. She has an M.A. in Transpersonal Psychology from Naropa University in Boulder, Colorado, and an M.F.A. in Fine Arts from the University of North Carolina at Greensboro. Marcela is a psychotherapist and an installation artist working in Boulder, Colorado. Her interest and focus on trauma has led her to understand the healing process as an intimate re-connection with one’s essence through love, integrity, acceptance, and honoring of the human spirit. In addition to working with trauma and PTSD, she has dedicated her professional life to teaching and research. She uses art as a vehicle for deepening the relationship to self, other, and the natural world. Marcela worked as a co-therapist in MAPS’ first government-approved MDMA-assisted psychotherapy study in Madrid, Spain, served as the Principal Investigator for MAPS’ Phase II MDMA-assisted psychotherapy study in Boulder, Colorado, and currently in the MDMA Healthy Volunteer study and Phase 3 site in Boulder, Colorado. Additionally, she is a trainer and supervisor for therapists working on MAPS studies for MDMA-assisted psychotherapy.
Carlos Plazola, M.E.S. Chair of Decriminalize Nature, CEO of The Haven CommunityRead Bio
Carlos Plazola, M.E.S.
At an early age, Carlos became confounded by the concept of the infinite and the end-of-life after learning about the death of a loved one. This obsession with understanding the existential questions carried him through various forms of childhood trauma that profoundly impacted those around him. Based on his desire to understand the nature of life, Carlos self-funded his way through college, working long hours, while also attending UCLA -- where Carlos received a B.S. degree in biology and anthropology. Seeking further growth, Carlos lived with the Achuar of Ecuador for several months, where Carlos saw, first-hand, the destruction of the rainforest and impact on ancient traditions. Carlos then obtained a master of science degree in environmental science from Yale University.
Upon graduating, Carlos sought the tools to create global change at the local level, organizing with the Silicon Valley Toxics Coalition, ACORN, and the Southwest Network for Environmental and Economic Justice. Carlos then spent 8 years learning the tools of political organizing, eventually becoming a field director for a mayoral campaign, and chief of staff to the Oakland Council President. His latest efforts since 2006 have been in manifesting creativity through the built environment, becoming a real estate developer, completing over 30 projects, including two mid-rises, and winning three Historic Preservation Awards, while also exploring and advancing methods of sustainable development.
Upon the passing of his mother in 2013, Carlos realized that the healing from his childhood trauma was not complete, despite years of effort, and Carlos immersed himself in seeking greater understanding by studying physics and participating in yoga and meditation. While these were helpful, they failed to reveal the answers Carlos sought. Carlos then engaged in two powerful and transformative journeys using psilocybin mushrooms and ayahuasca. These journeys finally provided him the answers to the existential questions he had sought his entire life and brought him the inner peace he sought.
Due to the power of this experience, Carlos has become an advocate for the decriminalization of entheogenic plants and fungi in a just and equitable way, ensuring they become accessible to all communities, especially to low-income communities which experience the highest levels of life-inhibiting trauma. To support this intention, Carlos is currently building a financially self-sustaining healing center called The Haven Community, a co-living, co-working consciousness community in Oakland, CA.
Andrea Turnipseed, LCSW-S Executive Director of Roots Behavioral HealthRead Bio
Andrea Turnipseed, LCSW-S
Andrea Turnipseed, LCSW-S, has training and background in adult mental health. She has worked with clients in acute inpatient and outpatient psychiatric settings, facilitating both group and individual therapy. She has a particular interest in working with individuals who experience mood disorders such as anxiety, depression, and bipolar disorder. She also helps clients through various life challenges such as grief and loss, relationship issues, parenting, and school and career stress. Andrea assesses each individual to guide the direction of therapy. Andrea has been formally trained in Ketamine-Assisted Psychotherapy (KAP) and she also utilizes techniques from psychodynamic, cognitive-behavioral (CBT), acceptance and commitment (ACT), solution-focused, and strengths-based therapy models to help identify the resources within the client to move past negative thoughts and behaviors. Andrea provides a non-judgmental space for clients to share events and difficulties. She asks questions and makes observations to help elicit positive change and growth. As Executive Director, Andrea is responsible for the overall health and well-being of Roots Behavioral Health.
Brent Turnipseed, M.D. Co-Founder and Medical Director of Roots Behavioral HealthRead Bio
Brent Turnipseed, M.D.
Brent Turnipseed is a co-founder and the Medical Director of Roots Behavioral Health. He is an affiliate member of the Center for Transformational Psychotherapy, and a trainer for the Ketamine Training Center. He lectures, researches, and teaches frequently on therapeutic uses of ketamine.
Clare S. Wilkins Founder & Director, Pangea BiomedicsRead Bio
Clare S. Wilkins
Clare S. Wilkins is a former intravenous IV drug user & methadone patient who shed those chemical dependencies with the aid of ibogaine in 2005. As founder of Pangea Biomedics, she has facilitated over 800 treatments with a diverse team & has collaborated with MAPS to study the long-term effects of patients undergoing detoxification therapy with ibogaine for opiates. (Brown, Alper M.D., 2017)
Since 2010 she has been an active board member of The Global Ibogaine Therapy Alliance (GITA); is co-author of the Clinical Guidelines for Ibogaine-Assisted Detoxification, a comprehensive risk-management resource & minimum standard of care for opioid detoxification. She is also co-author of a noteworthy case study (Wilkins, Bouso, Ph.D., et al 2017) published in the Journal of Psychedelic Studies. Mentored by Howard Lotsof, she is committed to advancing scientific research of iboga, including ibogaine, its alkaloids & analogs. She is currently collaborating with ICEERS in Spain, where a Phase 2 safety & efficacy study, using ibogaine for methadone patients has been approved, utilizing the cumulative administration method she developed over 13 years of clinical practice in Mexico.
Clare is also part of a cutting edge cohort of experts who are advancing Parkinson's Disease treatment, utilizing a successful combination of ibogaine, orthomolecular medicine & nootropics. As these case studies build, data gathered will contribute to new methods that can become open-source material for the safest and best outcomes. As a member of INPUD, an international drug user rights organization, Clare is devoted to reducing stigma & harm, promoting the health, dignity & cognitive liberty for people who use drugs, and every human’s basic right to compassion-based medicine.
Conference (Includes Saturday Celebration powered by Light Pump)
- $1000 – MAPS Patron (also includes Benefit Dinner and a special gift!) – SOLD OUT
- $450 – All Included Pass (also includes Benefit Dinner) – SOLD OUT
- $250 – General Admission – SOLD OUT
- $150 – Student Admission – SOLD OUT
Friday Benefit Dinner (à la carte)
Saturday Celebration(à la carte, powered by Light Pump)
Continuing Education (CE) Credits
- $65 – Up to 12 Credits Within 2 Days
Friday, November 1, 2019
7:00 PM – 10:00 PM
Meet & Greet Mixer
7:00 PM – 10:00 PM
MAPS Benefit Dinner (For dinner ticket holders only)
Saturday, November 2, 2019
9:30 AM – 9:45 AM
9:50 AM – 10:00 AM
10:00 AM – 11:00 AM
Updates from the Front Lines of Psychedelic Science
Rick Doblin, Ph.D.
MAPS Founder & Executive Director Rick Doblin, Ph.D., will share a detailed update on the progress of MAPS’ Phase 3 clinical research into MDMA-assisted psychotherapy for the treatment of PTSD, as well as updates on various other research initiatives being driven by MAPS.
11:00 AM – 11:30 AM
Microdosing Psychedelics: New Findings, Insights and Directions
Sophia Korb, Ph.D.
Microdosing psychedelics like LSD and psilocybin has become a recent media phenomenon, but the idea and practice of microdosing dates back to the inventor of LSD itself, Albert Hofmann, Ph.D.. One prominent figure in the most recent trend has been my mentor and co-researcher, Jim Fadiman. As microdosing emerged as a current trend, and as Jim and I expressed our interest to the psychedelics communities, letters and personal journals poured in. We found ways to systematize our processes, ask and attempt to answer scientifically valid questions, and learn along the way. I will be presenting some new findings on my research with Jim Fadiman, Ph.D. In our correspondence with over 4,000 people interested in microdosing from all over the world, we found some interesting, exceptional cases. I will be presenting some cases that inspired our follow up studies, made us say “what the…” and rethink our assumptions. We are currently focusing our energy on writing our results and follow-up studies, especially given the wide variation in age, education, conditions, substance and almost every other variable in our sample. This talk will serve to inform individuals already microdosing, the scientific community, and policymakers in the future.
11:30 AM – 12:00 PM
Ketamine Therapy: A Disruptive Treatment Paradigm
Andrea Turnipseed, LCSW-S & Brent Turnipseed, M.D.
Ketamine is a controversial yet effective treatment in psychiatry, and it arrives at a much needed time as depression and suicide rates have reached crisis levels in the United States. Attendees will learn about the origins of ketamine in medicine and how it has become one of the hottest topics today in mental health.
12:00 PM – 12:30 PM
Updates on Psychedelic Research from Heffter Research Institute
George Greer, M.D.
The Heffter Research Institute has been focused on psilocybin research for almost 20 years. Three years ago, two studies of psilocybin treatment for emotional distress in cancer patients were published, leading to the Usona Institute creating a Phase 3 project to attain FDA approval for psilocybin treatment of depression. Since then, Heffter has been involved in expanding psilocybin treatment research to other conditions, including addictions to tobacco, alcohol, cocaine, and opioids; depression; demoralization from AIDS, and obsessive-compulsive disorder; as well as the effects of psilocybin in long-term meditators. The current status of this research will be presented.
12:30 PM – 2:00 PM
Lunch Break (Lunch is not included, a list of nearby suggestions for meals is below.)
2:00 PM – 3:30 PM
Becoming a Psychedelic Therapist: Live Podcast Interview
Tim Ferriss and Marcela Ot’alora
One of the world’s most popular podcasters, Tim Ferriss, will cover the ins and outs of what it takes to become a psychedelic therapist with MAPS’ therapist trainer and Lead Principal Investigator for Phase 3 and Healthy Volunteer studies in Boulder, Colorado.
3:30 PM – 4:00 PM
4:00 PM – 4:30 PM
New Narratives & Cultural Frameworks for Healing Trauma
Mellody Hayes, M.D.
Let’s democratize the experience of freedom and liberation. Class, race, and gender may impact a person’s experience of suffering and are also important point of leverage for empowered healing. How can the clinical process be used to liberate people from the cycle of trauma? What frameworks exist to support movement towards wholeness, safety, and security and to create new narratives which birth new realities? Transformational medicine, as offered through psychedelics, can create access to emotional liberation, thereby increasing our will to increase social justice and ultimately health equity.
4:30 PM – 5:00 PM
Can Ayahuasca Promote Peace in the Middle East? Conversations with Palestinian and Israeli Ayahuasca Drinkers
Natalie Lyla Ginsberg, M.S.W.
A collaboration between MAPS and the Centre for Psychedelic Research at Imperial College London, Antwan Saca, Leor Roseman, Ph.D., and Natalie Ginsberg, M.S.W., interviewed 36 Palestinians and Israelis who drink ayahuasca in joint circles, in an effort to learn how ayahuasca might promote peace through collective healing and community building. Natalie will present a selection of interviewees’ stories, and speak to the themes emerging from these interviews.
5:00 PM – 5:30 PM
MDMA-Assisted Psychotherapy: Exploring the Role of Receptors, Neurons, and Brain Circuits
Alli Feduccia, Ph.D.
MDMA-assisted psychotherapy is under investigation as a novel treatment for posttraumatic stress disorder (PTSD). This treatment approach has recently progressed to Phase 3 clinical trials and received Breakthrough Therapy designation by the FDA in 2017. The underlying psychological and neurological mechanisms for the robust effects in mitigating PTSD symptoms are being studied in animal models and in studies of healthy volunteers. This presentation will explore the potential role of memory re-consolidation and fear extinction during MDMA-assisted psychotherapy, as well as the contribution of signaling molecules that modulate emotional memory circuits and neuroplasticity. Determining who is unlikely to respond to this intensive drug-therapy combination is of clinical interest. Tapering of antidepressant medications re-uptake inhibitor that target the same principal receptors as MDMA can potentially impact the subjective and psychological effects of MDMA. Unpublished data from four phase 2 trials of MDMA-assisted psychotherapy will be presented showing differential treatment and physiological responses between participants who tapered and those that did not.
5:30 PM – 6:30 PM
PANEL: Considerations for the Mainstreaming of Psychedelics: From Culture to Commercialization
Allison Feduccia, Ph.D., George Greer, M.D., Mellody Hayes, M.D., Brent Turnipseed, M.D., Bia Labate, Ph.D. (Moderator)
This panel will explore considerations for the responsible integration of psychedelic medicines into society.
6:30 PM – 6:35 PM
6:35 PM – 8:00 PM
8:00 PM – 12:00 AM
Celebration (Powered by Light Pump)
Sunday, November 3, 2019
Doors Open to Public
10:00 PM – 10:10 AM
10:10 AM – 11:00 AM
A Grown-up Conversation about Drugs and Race
Carl Hart, Ph.D.
In this talk, Hart will discuss findings from laboratory research with cannabis, cocaine, and amphetamines (including MDMA). Despite the fact that data from such studies indicate predominantly positive effects, many of these drugs are tightly restricted. Each year, hundreds of thousands of Americans are arrested for simply possessing these drugs. What’s worse, drug law enforcement is carried out in a racist manner. This point and the extensive racial trauma caused by current drug policies have been largely ignored by the psychedelic community. The talk will conclude with recommendations for the psychedelic community as well as the broader society.
11:00 AM – 12:30 PM
PANEL: Psychedelic Policy: Frameworks for Legal Access to Psychedelics
Carlos Plazola, M.E.S., Natalie Ginsberg, M.S.W., (Moderator), Betty Aldworth, Sandor Iron Rope, Jax Finkel
What is the role of policy reform in the advancement of psychedelics? This year, Denver passed a measure effectively decriminalizing psilocybin and Oakland followed suit by expanding its passing resolution to “decriminalize nature,” including all psychedelic plants and fungi. Many other cities, including Chicago, have quickly been working to replicate their success. Californians are working to see a state-wide referendum to legalize psilocybin, and the people of Oregon will vote on an initiative to create a state-overseen psilocybin therapeutic access program. Psychedelics, like cannabis, enjoy rare nonpartisan support. What unique bipartisan and nonpartisan opportunities does psychedelic policy reform offer? What can we learn from the mistakes of cannabis reform? How can psychedelic policy reform build with those who have been working to end the war on drugs for decades, and elevate those who have been most impacted by psychedelic prohibition — indigenous communities who have been in relation with plant medicine for millennia?
12:30 PM – 2:00 PM
Lunch Break (Lunch is not included, a list of nearby suggestions for meals is below.)
2:00 PM – 2:30 PM
Community Care: The Zendo Project for Psychedelic Harm Reduction
Sara Gael, M.A.
We envision a world where communities are engaged in providing safety and support for people having psychedelic and psychological challenges; and harm reduction principles are used foremost to reduce the risks associated with substance use.
2:30 PM – 2:45 PM
Community Voices: How to Get Engaged
2:45 PM – 3:00 PM
3:00 PM – 3:30 PM
Indigenous Peyote Way of Life
Sandor Iron Rope
Sandor Iron Rope, President of the Native American Church of South Dakota and Board of Directors of the Indigenous Peyote Conservation Initiative, will discuss the indigenous reconnection to spiritual harvest of their medicine. Mental and community health of indigenous peoples, cultural sovereignty which can address addiction and suicide (rampant in native communities) requires a clean and direct connection with their land and medicine and includes language and ceremony preservation. Native people are creating their own strategies for restoring these connections and protecting their way of life for generations to come through Indigenous peyote conservation. This includes protection, tending their own land and medicine and educating both native american church members and non-native allies in how to protect this sacred heritage.
3:30 PM – 4:00 PM
The Architecture of Emergency: Ibogaine & Psychedelic Use in the Anthropocene Era
Clare S. Wilkins
Ibogaine, as well as other psychedelics, have been gaining traction within the medical model, as the shamanic approach continues. Both methods can emphasize a power dynamic wherein the patient or client forfeits agency to the doctor or shaman, or to the medicine itself, and the remedy is often seen as coming from outside, rather than from within. This perspective can result in people continuing to feel the need for treatment, remaining sick, and continuing to harm themselves unconsciously, in order to receive continued care or simply to connect. Many see ibogaine as a fast, one-time fix, which correlates with a culture that emphasizes production, imbalanced power structures, human arrogance, rapid communication, and results. This can be dangerous, as adverse events occur during or after treatment when spaciousness, details, and nuances are ignored. We have found that moving away from the frenetic pace of mechanical, modern life into a safe territory, and delving into the inner mechanics of the unconscious mind, beyond the walls of ego protection, requires presence, compassionate support, continued connection, and a radical sense of inclusivity in order to truly accept oneself and others; in order to evolve during these dire times.
4:00 PM – 4:45 PM
PANEL: Service Members & Family Share Experiences with Psychedelics
SGT(R) Jonathan Lubecky, Amber Capone, Marcus Capone, Ian Benouis (Moderator)
Given the PTSD and suicide epidemic within the military and veteran communities, nothing should be left off the table in terms of treatment options. All potential options should be considered. Hear from veterans who have benefited from the therapeutic uses of psychedelics. Hear from voices of Veterans and veterans wife about how their lives were transformed through the careful use of psychedelic-assisted therapies
4:45 PM – 5:45 PM
Psilocybin Mushrooms & Their Emergent Medicines
This talk will discuss the history of psilocybin mushroom use and how we got to the present, which Paul Stamets considers the Third Wave in the psilocybin pharmacotheon. He will discuss his team’s current research and near future opportunities. Results on psilocybin analogs on neurogenesis will be described.
5:45 PM – 6:30 PM
PANEL: What Does the Near Future Hold?
Paul Stamets, Carl Hart, Ph.D., Rick Doblin, Ph.D., Natalie Ginsberg, M.S.W., Betty Aldworth, Liana Gillooly (Moderator)
6:30 PM – 6:45 PM
Closing Statements and Gratitude
CE credits for psychologists are provided by the Spiritual Competency Resource Center (SCRC), which is co-sponsoring this program. The Spiritual Competency Resource Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The Spiritual Competency Resource Center maintains responsibility for this program and its content. At least 12 CE hours will be available.
The California Board of Behavioral Sciences accepts CE credits for LCSW, LPCC, LEP, and LMFT license renewal for programs offered by approved sponsors of CE by the American Psychological Association.
LCSWs, MFTs, and other mental health professionals from states other than California need to check with their state licensing board as to whether or not they accept programs offered by approved sponsors of CE by the American Psychological Association.
SCRC is approved by the California Board of Registered Nursing (BRN Provider CEP16887) for licensed nurses in California.
For questions about receiving your Certificate of Attendance, contact MAPS at firstname.lastname@example.org. For questions about CE, visit spiritualcompetency.com or contact David Lukoff, Ph.D., at CE@spiritualcompetency.com.
Frequently Asked Questions (FAQ)
Where is the event located?
This event is hosted at Fair Market, located at 1100 East 5th Street, Austin, TX 78702.
When is the event happening?
This event will take place from Friday, November 1 through Sunday, November 3, 2019.
When does registration close?
Tickets will be available for purchase online until 48 hours prior to the event or until tickets are sold out. Tickets may be available at the door. Space is limited and interested parties are encouraged to buy tickets promptly to secure attendance.
What lodging options are available?
MAPS has identified multiple budget-friendly hotel and motel options. When calling to book, mention that you are with the group “MAPS” for a check-in date of November 1 to get the best rate possible.
Red Roof Inn
8210 North Interstate 35
Motel 6 Austin
2707 Interregional Hwy S
Drury Inn & Suites Austin North
6711 I-35 North
Homewood Suites by Hilton Austin-Arboretum/NW
10925 Stonelake Blvd
TownePlace Suites Austin Arboretum/The Domain Area
10024 N Capital of TX HWY North
Country Inn & Suites By Radisson, Austin-University, TX
7400 N I-35 Frontage Rd
Courtyard Austin Northwest/Arboretum
9409 Stonelake Blvd
Residence Inn Austin North/Parmer Lane
12401 N Lamar Blvd
Residence Inn Austin Northwest/Arboretum
3713 Tudor Blvd
SpringHill Suites Austin North/Parmer Lane
12520 North IH-35
Due to other events in the Austin area, we expect lodging options to decrease as we get closer to the event, so we encourage you to secure lodging as soon as you can. You may also find affordable lodging options on housing rental sites such as AirBnB and VRBO.
What is the cancellation/refund policy?
Refund requests will be accepted until 2 business days prior to the event. All refunds require a 3% processing fee. Please allow 5-10 business days to process your refund. To request a refund, send your email registration receipt to email@example.com along with your name, the email address you used to register, and the reason for your refund request. The name and email on the registration must match the email from which the request is sent.
Can someone else attend in my place?
To request a transfer, forward your email registration receipt to firstname.lastname@example.org, along with the name and email of the person who will receive your ticket(s). The name and email on the registration must match the email from which the request is sent. Any and all financial transactions associated with the transfer of event ticket registration are the responsibility of the ticketholder.
Is my ticket purchase tax-deductible?
A portion of ticket prices may be tax-deductible. Please contact email@example.com for details.
Will continuing education credit be available?
Yes, click here to learn more about continuing education credit.
Are there volunteer opportunities for this event?
Yes, a limited number of volunteer opportunities are available for this event. You may apply as a volunteer by visiting this link.
Still have questions?
Please write to us at firstname.lastname@example.org.
Partners & Exhibitors
By becoming an official Partner or Exhibitor at the Psychedelic Science Summit, you’ll join us at the forefront of the psychedelic research renaissance and help shape a new global psychedelic culture. As a Partner or Exhibitor, you’re making the Psychedelic Science Summit possible. Partners and Exhibitors receive recognition for their support and participation through advance publicity, onsite visibility, and enduring multimedia exposure after the event. All proceeds support MAPS, and are partially or fully tax-deductible as provided by law.
Wish to participate as a Partner or Exhibitor? Click here to learn more or send an email to email@example.com
Transforming Capital Institute